New Trial Alert: Alliance A031803 Non-muscle Invasive Bladder Cancer

January 6, 2020

Alliance A031803: Phase II trial of intravesical gemcitabine and MK-3475 (pembrolizumab) in the treatment of patients with BCG-unresponsive non-muscle invasive bladder cancer

Overview: Alliance investigator Michael Woods, MD, of Loyola University Medical Center, leads this phase II trial to see how well gemcitabine together with pembrolizumab works in treating patients with non-muscle invasive bl

New Trial: Alliance A031801 Advanced Renal Cell Cancer

December 16, 2019

Alliance A031801: A phase II randomized trial of radium-223 dichloride and cabozantinib in patients with advanced renal cell carcinoma with bone metastasis (RadiCal)

Overview: Alliance investigator Rana R. McKay, MD, of the University of California San Diego, leads this phase II trial to see whether adding radium-223 dichloride to the usual treatment, cabozantinib, improves outcome in patients with renal cel

Happy Holidays from Alliance

December 16, 2019

May the holiday spirit be with you and your family throughout the New Year. 

Have a safe and happy holiday season.

In observance of Christmas and New Year's Day, Alliance Chicago and Boston Offices will be closed Monday, December 23 through Wednesday, December 25, and Monday, December 30 through Wednesday, January 1. The Alliance Boston Office will have tech support available for critical issues only Mond

Older News